View in EDS

Drug Repurposing in Pancreatic Cancer: A Multi-Stakeholder Perspective to Improve Treatment Options for Pancreatic Cancer Patients.

Saved in:
Bibliographic Details
Title: Drug Repurposing in Pancreatic Cancer: A Multi-Stakeholder Perspective to Improve Treatment Options for Pancreatic Cancer Patients.
Authors: Hewitt E; Beacon: for Rare Disease, Cambridge, UK., Bouche G; The Anticancer Fund, Meise, Belgium., Alencar AC; Rising Tide Foundation for Clinical Cancer Research, Schaffhausen, Switzerland., Bigelsen SJ; Patient Advocate, Department of Allergy, Asthma and Immunology, Rutgers New Jersey Medical School, Newark, NJ, USA., Radu R; Medicines for Europe, Brussels, Belgium., Stoyanova-Beninska V; College ter Beoordeling van Geneesmiddelen, Utrecht, the Netherlands., Carrato A; Department of Medical Oncology, Alcalá University, Instituto Ramón Y Cajal de Investigación Sanitaria (IRYCIS), Centro de Investigación Biomédica En Red de Cáncer (CIBERONC), Ramon Y Cajal University Hospital, Madrid, Spain.; Pancreatic Cancer Europe, Brussels, Belgium., Valsecchi F; Fondazione Nadia Valsecchi, Brescia, Italy., Soler Cantón A; EATRIS ERIC, European Infrastructure for Translational Medicine, Amsterdam, the Netherlands., van der Meer HG; ZonMw, The Hague, the Netherlands., García Bermejo ML; Biomarkers and Therapeutic Targets Group, Instituto Ramón Y Cajal de Investigación Sanitaria (IRYCIS), Ramon Y Cajal University Hospital, Madrid, Spain., Budillon A; Scientific Directorate, Istituto Nazionale Tumori - IRCCS - Fondazione G. Pascale, Naples, Italy., Cardone L; Institute of BiOChemistry and Cell Biology (IBBC), CNR c/o Campus Internazionale 'a.buzzati-Traverso', Monterotondo Scalo Roma (Rome), Italy.; Department of Tumour Immunology and Immunotherapy, IRCCS Regina Elena National Cancer Institute, Rome, Italy., Rooman I; The Anticancer Fund, Meise, Belgium.; Translational Oncology Research Center (TORC), Laboratory of Medical and Molecular Oncology, (LMMO) Vrije Universiteit Brussel, Brussels, Belgium., Platteeuw H; Galenicap, Brussels, Belgium., Baijet J; EURORDIS - Rare Diseases Europe, Paris, France., Fuchs C; EURORDIS - Rare Diseases Europe, Paris, France.
Source: Cancer management and research [Cancer Manag Res] 2025 Mar 01; Vol. 17, pp. 429-440. Date of Electronic Publication: 2025 Mar 01 (Print Publication: 2025).
Publication Type: Journal Article
Journal Info: Publisher: Dove Medical Press Country of Publication: New Zealand NLM ID: 101512700 Publication Model: eCollection Cited Medium: Print ISSN: 1179-1322 (Print) Linking ISSN: 11791322 NLM ISO Abbreviation: Cancer Manag Res Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 40046652
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Drug Repurposing in Pancreatic Cancer: A Multi-Stakeholder Perspective to Improve Treatment Options for Pancreatic Cancer Patients.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Hewitt+E%22">Hewitt E</searchLink>; Beacon: for Rare Disease, Cambridge, UK.<br /><searchLink fieldCode="AU" term="%22Bouche+G%22">Bouche G</searchLink>; The Anticancer Fund, Meise, Belgium.<br /><searchLink fieldCode="AU" term="%22Alencar+AC%22">Alencar AC</searchLink>; Rising Tide Foundation for Clinical Cancer Research, Schaffhausen, Switzerland.<br /><searchLink fieldCode="AU" term="%22Bigelsen+SJ%22">Bigelsen SJ</searchLink>; Patient Advocate, Department of Allergy, Asthma and Immunology, Rutgers New Jersey Medical School, Newark, NJ, USA.<br /><searchLink fieldCode="AU" term="%22Radu+R%22">Radu R</searchLink>; Medicines for Europe, Brussels, Belgium.<br /><searchLink fieldCode="AU" term="%22Stoyanova-Beninska+V%22">Stoyanova-Beninska V</searchLink>; College ter Beoordeling van Geneesmiddelen, Utrecht, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Carrato+A%22">Carrato A</searchLink>; Department of Medical Oncology, Alcalá University, Instituto Ramón Y Cajal de Investigación Sanitaria (IRYCIS), Centro de Investigación Biomédica En Red de Cáncer (CIBERONC), Ramon Y Cajal University Hospital, Madrid, Spain.; Pancreatic Cancer Europe, Brussels, Belgium.<br /><searchLink fieldCode="AU" term="%22Valsecchi+F%22">Valsecchi F</searchLink>; Fondazione Nadia Valsecchi, Brescia, Italy.<br /><searchLink fieldCode="AU" term="%22Soler+Cantón+A%22">Soler Cantón A</searchLink>; EATRIS ERIC, European Infrastructure for Translational Medicine, Amsterdam, the Netherlands.<br /><searchLink fieldCode="AU" term="%22van+der+Meer+HG%22">van der Meer HG</searchLink>; ZonMw, The Hague, the Netherlands.<br /><searchLink fieldCode="AU" term="%22García+Bermejo+ML%22">García Bermejo ML</searchLink>; Biomarkers and Therapeutic Targets Group, Instituto Ramón Y Cajal de Investigación Sanitaria (IRYCIS), Ramon Y Cajal University Hospital, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Budillon+A%22">Budillon A</searchLink>; Scientific Directorate, Istituto Nazionale Tumori - IRCCS - Fondazione G. Pascale, Naples, Italy.<br /><searchLink fieldCode="AU" term="%22Cardone+L%22">Cardone L</searchLink>; Institute of BiOChemistry and Cell Biology (IBBC), CNR c/o Campus Internazionale 'a.buzzati-Traverso', Monterotondo Scalo Roma (Rome), Italy.; Department of Tumour Immunology and Immunotherapy, IRCCS Regina Elena National Cancer Institute, Rome, Italy.<br /><searchLink fieldCode="AU" term="%22Rooman+I%22">Rooman I</searchLink>; The Anticancer Fund, Meise, Belgium.; Translational Oncology Research Center (TORC), Laboratory of Medical and Molecular Oncology, (LMMO) Vrije Universiteit Brussel, Brussels, Belgium.<br /><searchLink fieldCode="AU" term="%22Platteeuw+H%22">Platteeuw H</searchLink>; Galenicap, Brussels, Belgium.<br /><searchLink fieldCode="AU" term="%22Baijet+J%22">Baijet J</searchLink>; EURORDIS - Rare Diseases Europe, Paris, France.<br /><searchLink fieldCode="AU" term="%22Fuchs+C%22">Fuchs C</searchLink>; EURORDIS - Rare Diseases Europe, Paris, France.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101512700%22">Cancer management and research</searchLink> [Cancer Manag Res] 2025 Mar 01; Vol. 17, pp. 429-440. <i>Date of Electronic Publication: </i>2025 Mar 01 (<i>Print Publication: </i>2025).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Dove+Medical+Press%22">Dove Medical Press </searchLink><i>Country of Publication: </i>New Zealand <i>NLM ID: </i>101512700 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Print <i>ISSN: </i>1179-1322 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2211791322%22">11791322 </searchLink><i>NLM ISO Abbreviation: </i>Cancer Manag Res <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40046652
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.2147/CMAR.S483151
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 429
    Titles:
      – TitleFull: Drug Repurposing in Pancreatic Cancer: A Multi-Stakeholder Perspective to Improve Treatment Options for Pancreatic Cancer Patients.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Hewitt E
      – PersonEntity:
          Name:
            NameFull: Bouche G
      – PersonEntity:
          Name:
            NameFull: Alencar AC
      – PersonEntity:
          Name:
            NameFull: Bigelsen SJ
      – PersonEntity:
          Name:
            NameFull: Radu R
      – PersonEntity:
          Name:
            NameFull: Stoyanova-Beninska V
      – PersonEntity:
          Name:
            NameFull: Carrato A
      – PersonEntity:
          Name:
            NameFull: Valsecchi F
      – PersonEntity:
          Name:
            NameFull: Soler Cantón A
      – PersonEntity:
          Name:
            NameFull: van der Meer HG
      – PersonEntity:
          Name:
            NameFull: García Bermejo ML
      – PersonEntity:
          Name:
            NameFull: Budillon A
      – PersonEntity:
          Name:
            NameFull: Cardone L
      – PersonEntity:
          Name:
            NameFull: Rooman I
      – PersonEntity:
          Name:
            NameFull: Platteeuw H
      – PersonEntity:
          Name:
            NameFull: Baijet J
      – PersonEntity:
          Name:
            NameFull: Fuchs C
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 03
              Text: 2025 Mar 01
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-print
              Value: 1179-1322
          Numbering:
            – Type: volume
              Value: 17
          Titles:
            – TitleFull: Cancer management and research
              Type: main
ResultId 1